Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Other Non Operating Income (2021 - 2026)

Journey Medical filings provide 5 years of Other Non Operating Income readings, the most recent being -$19000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to -$19000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$90000.0, a 108.4% decrease, with the full-year FY2025 number at -$90000.0, down 108.0% from a year prior.
  • Other Non Operating Income hit -$19000.0 in Q4 2025 for Journey Medical, down from -$3000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q3 2024 to a low of -$263000.0 in Q4 2021.
  • Median Other Non Operating Income over the past 5 years was -$27000.0 (2022), compared with a mean of $16437.5.
  • Biggest five-year swings in Other Non Operating Income: plummeted 1000.0% in 2022 and later skyrocketed 1213.86% in 2024.
  • Journey Medical's Other Non Operating Income stood at -$263000.0 in 2021, then skyrocketed by 74.52% to -$67000.0 in 2022, then surged by 97.01% to -$2000.0 in 2023, then soared by 56350.0% to $1.1 million in 2024, then plummeted by 101.69% to -$19000.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$19000.0 (Q4 2025), -$3000.0 (Q3 2025), and -$61000.0 (Q2 2025) per Business Quant data.